EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Rhea-AI Summary

EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, has scheduled its Fourth Quarter and Full Year 2024 financial results announcement for March 27, 2025, before markets open. The company will host a conference call and webcast at 8:30 AM EDT on the same day.

The earnings discussion will be led by Ryan Rhodes (CEO), Ken Mobeck (CFO), and François Dietsch (Chief Accounting Officer). Interested parties can access the call through domestic (1-800-225-9448) or international (1-203-518-9708) dial-in numbers using the passcode EDAP.

News Market Reaction

+0.41%

1 alert

+0.41% News Effect

On the day this news was published, EDAP gained 0.41%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Company to host conference call and webcast on Thursday, March 27^th at 8:30am EDT

AUSTIN, Texas, March 6, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2024, before the markets open on Thursday, March 27^th, 2025.

An accompanying conference call and webcast will be conducted by Ryan Rhodes, Chief Executive Officer, Ken Mobeck, Chief Financial Officer, and François Dietsch, Chief Accounting Officer. Please refer to the information below for conference call dial-in information and webcast registration.

Call Details:

Date:                Thursday, March 27^th

Time:                 8:30 am EDT

Domestic:        1-800-225-9448

International:    1-203-518-9708

Passcode:        EDAP

Webcast:         https://viavid.webcasts.com/starthere.jsp?ei=1706804&tp_key=5b71915afc

About EDAP TMS SA

A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP TMS introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com.

Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com

Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com

FAQ

When will EDAP release its Q4 and Full Year 2024 financial results?

EDAP will release its Q4 and Full Year 2024 financial results before markets open on Thursday, March 27th, 2025.

What time is EDAP's Q4 2024 earnings conference call?

EDAP's earnings conference call is scheduled for 8:30 AM EDT on Thursday, March 27th, 2025.

Who will be presenting at EDAP's Q4 2024 earnings call?

The call will be led by CEO Ryan Rhodes, CFO Ken Mobeck, and Chief Accounting Officer François Dietsch.

What are the dial-in numbers for EDAP's Q4 2024 earnings call?

The domestic dial-in number is 1-800-225-9448, and the international number is 1-203-518-9708, with passcode EDAP.